Anti-MERS-CoV Drug Discovery Products

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a member of the Betacoronavirus genus within the Coronaviridae family, a group of viruses that are known for their ability to cause severe respiratory infections in humans and other animals. This virus, first discovered in Saudi Arabia in 2012, caused hundreds of cases of human infection with a high mortality rate. The MERS-CoV infection causes severe respiratory symptoms in humans, making it a particularly virulent and dangerous virus.

The MERS-CoV genome is a single-stranded positive-sense RNA with approximately 30kb in length. The genome encodes several structural proteins including the spike, envelope, nucleocapsid, and membrane protein. The S protein plays an essential role in binding to the host cell receptor. Creative Biolas provides excellent tools for researchers aiming to understand the biology of MERS-CoV and develop effective vaccines and treatments against MERS-CoV.